Rexam Share Discussion Threads

[wad collector] 19/5/2014 13:35

Sold some at 516p. Happy to look for short term weakness to buy back.

[wad collector] 07/5/2014 08:30

Xd 11.7P today.

[deanforester] 06/5/2014 11:21

Next Tuesday for news of the return of Capital, then.

[wad collector] 02/5/2014 08:31

False dawn ; IMS was "in line".
That will have to do.

[wad collector] 01/5/2014 16:33

Nice little late rise before the close ; I like that the day before results . Always makes me think of a little leak of Good News.

[broadwood] 01/5/2014 16:29

Figures tomorrow.

[wad collector] 14/3/2014 09:09

Picked up some more at 483 yesterday ; looks like in another share price trough.

[deadly] 20/2/2014 18:45

The drop was just nonsense on those results. This is a strong, reliable company which will do well through thick and thin, and increasingly pays out cash.
I bought in again early today, and tried to get more cheaply but it rose too quickly.

[wad collector] 20/2/2014 12:15

Interesting share price response to the results - down 10% then back up 5% .
The Market was clearly expecting even better things ; I missed the opportunity to top up cheaply there. Sit on hands time for me.

[bulltradept] 20/2/2014 09:12

Sometimes it's better to travel than arrive..

[deadly] 20/2/2014 09:02

So why the 10% drop?

[broadwood] 20/2/2014 07:28

Consumer packaging company Rexam reported sales up 1% at £3.943bn for the full-year 2013, with underlying profit before tax up 4% at £372m.

Underlying earnings per share were up 13% at 35.3p.

A final dividend of 11.7p per share will be paid, making a total dividend of 17.4p for the year. This is a 14% increase.

Graham Chipchase, CEO, said:

"We are pleased to have achieved our 15% ROCE target. We also grew 2013 profits by 4% and have proposed a 14% increase in the dividend to 17.4p. It has been a great team effort.

"The acquisition of a majority stake in UAC expands our footprint in the Middle East, while our investment in Magnaparva Packaging demonstrates our intent to pursue transformational innovation opportunities.

"Rexam is now a focused beverage can maker, and our aim is to be the best in the industry. The work that we have done to restructure our company means that we are in good shape operationally. In 2014, despite an uncertain macroeconomic environment and some continued cost volatility, we expect to make further progress on a constant currency basis. We remain committed to managing what we can control and focusing on cash, cost and return on capital employed as we pursue our strategy of balancing growth and returns."

[broadwood] 20/2/2014 07:13

Another special div.

[wad collector] 17/2/2014 09:00

This looks like it is moving towards a six year high. A reasonable exit point or a ledge on a bigger climb?

[wad collector] 14/2/2014 14:13

I am pleased to see they bought something relevant with the cash not just handing it all out.

Rexam acquires majority stake in Middle East beverage can maker

Rexam PLC, a leading global beverage can maker, announces that it has signed an agreement to acquire a 51% stake in beverage can maker United Arab Can Manufacturing Limited (UAC) for US$122m. The transaction is subject to regulatory approvals and is expected to complete in Q3 2014.

UAC makes beverage cans and can ends and is situated in Dammam, Saudi Arabia. The plant has an annual capacity of 1.8bn cans in both standard and specialty sizes. In 2012, the company generated EBITDA of c $29m.

Current shareholders of UAC comprise Olayan Financing Company, Aujan Industries Co. LLC, The Coca-Cola Bottling Company of Saudi Arabia and Al-Jabr Trading Company. All will continue to be shareholders in the company, which is to be renamed Rexam UAC, following the transaction.

Graham Chipchase, Rexam's Chief Executive said:

"We have spoken for some time about the opportunities in emerging markets and I am delighted that we are seeing our strategy bear fruit with the acquisition of a controlling stake in United Arab Can.

UAC is a modern business with respected partners, well established customer relationships, a strong competitive position in an attractive market with good returns. While the plant is operating well, given our own global scale and technical expertise, we see a number of opportunities for synergies.

Growth prospects for the beverage can in the Middle East are attractive and we look forward to working together with our partners in UAC to lead further expansion in the region."

[wad collector] 12/2/2014 12:37

The heathcare sale is progressing ; seems like only yesterday they had a rights issue.
The return to shareholders will be around 56p.


4

3 February 2014

Rexam announces proposed sale of the Pharmaceutical Devices and Prescription Retail Packaging divisions of its Healthcare business and a return of cash to shareholders of around GBP450m

Rexam PLC, a leading global beverage can maker, announces the proposed sale of the Pharmaceutical Devices and Prescription Retail Packaging divisions of its Healthcare business for $805m in cash.

The Healthcare business has three divisions: Pharmaceutical Devices, Prescription Retail Packaging and Closures & Containers. Rexam is in discussions regarding the sale of Closures & Containers and will provide an update in due course.

Montagu Private Equity has made a binding offer for the Pharmaceutical Devices and Prescription Retail Packaging divisions for a total of $805m in cash. The transaction is subject to consultation with various European works councils and is conditional on the necessary regulatory approvals and subject to certain adjustments at completion. The transaction is expected to complete around the middle of this year.

In 2012, Pharmaceutical Devices and Prescription Retail Packaging employed some 1,500 people and had sales of c.GBP250m and underlying operating profit of c.GBP43m before central overheads. As at 31 December 2012, it had gross assets of c.GBP538m. Pharmaceutical Devices and Prescription Retail Packaging accounts for c.85% of total Healthcare EBITDA.

Following completion of the sale of Pharmaceutical Devices and Prescription Retail Packaging, Rexam plans to return to shareholders around GBP450m, which, it is anticipated, will be effected by way of a redeemable B share scheme together with a share consolidation.

Graham Chipchase, Rexam's Chief Executive said: "The sale of the Healthcare business is part of our long term strategy to maximise shareholder value. The Pharmaceutical Devices and Prescription Retail Packaging divisions represent the majority of the value of our Healthcare business. Following the sale of Healthcare, we will be a focused beverage cans business with a strong financial position. Our strategy is to balance growth and returns and we will continue to pursue selective investment opportunities in beverage cans in higher growth markets."

[wad collector] 15/1/2014 16:17

20 February 2014

Announcement of 2013 full year results

Perhaps share price is moving up in expectation of good things ahead?

[broadwood] 31/12/2013 09:00

Heading past recent highs. Six weeks to finals.

[wad collector] 28/11/2013 09:40

Patience being rewarded this week ; will this challenge 530 again soon?
Given up looking for logic in these changes - go with the flow...

[wad collector] 21/11/2013 11:52

Bought my trading stake back in at 486 - 5% in a month not to be sniffed at , and no dividend missed.

[wad collector] 18/11/2013 09:38

So much for the promising looking chart last week!
Patience required. Again.

[masurenguy] 14/11/2013 08:03

I thought that this was a bit downbeat !
"Looking into next year, while we anticipate some volume growth, we will have to contend with the difficult macroeconomic backdrop in Europe, the impact of a maturing specialty can market in North America and foreign exchange translation headwinds."

[broadwood] 14/11/2013 07:41

Steady as she goes.

[yoyoy] 14/11/2013 07:24

looks ok to me